Mustafa Özdoğan, MD X Hesabı İstatistikleri

X Hesabı

http://x.com/ozdogan_md

Son Kontrol : 14.12.2025

Takipçisi 6.540

Takip Edilen 1.012

Sektör

Tweetler	Beğeni	Retweet	Etkileşim
The #FDA has officially approved niraparib + abiraterone for BRCA2-mutated metastatic Hormone-Sensitive Prostate Cancer (#mCSPC). This approval moves PARP inhibitors to the front line. We are no longer waiting for castration resistance. The...	22	11	%1,04
Immunotherapy may soon have an “early warning system.” #NEJM correspondence shows tissue-specific cfDNA can detect immune-related organ damage months before symptoms appear—with 100% sensitivity and no false positives in this proof-of-concept...	10	7	%0,61
#SABCS25 Is ctDNA predictive here? Not formally—yet. But studies like this move ctDNA beyond a purely prognostic marker. When ctDNA status is used to guide treatment de-escalation decisions and consistently identifies patients who do not need...	10	5	%0,46

Tweetler	Tarih	Beğeni	Retweet	Etkileşim

Tweetler	Tarih	Beğeni	Retweet	Yorum	Görüntülenme

Takipçi : 6.540

Web sitesi : https://t.co/5DClntnZdr

Kullanıcı : ozdogan_md

Tanıtım :

Sayfa ile ilgili istek ve şikayetleriniz için aşağıdaki formu kullanabilirsiniz.